{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:23:46Z","timestamp":1790753026519,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatitis B virus (HBV) infection is one of the major public health problems worldwide. Limited information exists about the epidemiology of HBV infection in Ethiopia. This study aimed to assess sero-prevalence of HBV markers and associated factors in children living in Hawassa City, southern Ethiopia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A community-based cross-sectional study was conducted among 471 children in Hawassa City, southern Ethiopia from May to September, 2018. A total of 471 children were included in the study using a multistage sampling technique. Data on demographic and risk factors were gathered using structured questionnaires. Blood samples were collected and sera were screened for hepatitis B surface antigen (HBsAg), antibody to core antigen (anti-HBc), and antibody against surface antigen (anti-HBs) using enzyme-linked immunosorbent assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The sero-prevalence of HBsAg, anti-HBc, and anti-HBs markers among children were 4.4, 19.5 and 20.0%, respectively. Children at higher risk of having HBsAg marker were those who had a history of injectable medications (AOR 5.02, 95% CI: 1.14, 22.07), a family history of liver disease (AOR 6.37, 95% CI: 1.32, 30.74), a HBsAg seropositive mothers, (AOR 11.19, (95% CI: 3.15, 39.67), and had no vaccination history for HBV (AOR, 6.37, 95% CI: 1.32, 30.74). Children from families with low monthly income, who were home delivered, unvaccinated for HBV or with HBsAg seropositive mother had increased risk of having anti-HBc.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study findings showed an intermediate endemicity of HBV infection in the study setting. The observed rate of residual HBV infection with low rate of immunized children after HBV vaccination was high. Hence, introducing birth dose vaccine, safe injection practice and improving immunization coverage during pregnancy as part of the antenatal care package should be considered. Furthermore, governmental and non-governmental organizations should give attention on timely measures for the prevention of ongoing vertical transmission from mother to child as well as early horizontal transmission of HBV in Hawassa City, Ethiopia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05229-7","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T09:07:57Z","timestamp":1595408877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia"],"prefix":"10.1186","volume":"20","author":[{"given":"Bedru","family":"Argaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adane","family":"Mihret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeb","family":"Tarekegne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siraj","family":"Hussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demelash","family":"Wachamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Techalew","family":"Shimelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawleigh","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"5229_CR1","unstructured":"World Health Organization, Guidelines for the Prevention Care and Treatment of Persons with Chronic Hepatitis B Infection: Geneva: World Health Organization; 2015."},{"key":"5229_CR2","doi-asserted-by":"crossref","unstructured":"Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol: WJG 2014;20(18):5427.","DOI":"10.3748\/wjg.v20.i18.5427"},{"key":"5229_CR3","unstructured":"WHO. World health statistics 2016: monitoring health for the SDGs sustainable development goals: World Health Organization; 2016."},{"key":"5229_CR4","doi-asserted-by":"crossref","unstructured":"Disease G B D, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1211\u201359.","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"5229_CR5","unstructured":"Global Health Estimates. Deaths by cause, age, sex, by country and by region, 2000\u20132015. Geneva: World Health Organization. 2015;2016."},{"issue":"4","key":"5229_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3904\/kjim.2013.28.4.413","volume":"28","author":"H Kim","year":"2013","unstructured":"Kim H, Shin AR, Chung HH, Kim MK, Lee JS, et al. Recent trends in hepatitis B virus infection in the general Korean population. The Korean journal of internal medicine. 2013;28(4):413.","journal-title":"The Korean journal of internal medicine"},{"key":"5229_CR7","doi-asserted-by":"crossref","unstructured":"Hwang E W, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. North American Journal of Medicine and Science. 2011;4(1).","DOI":"10.7156\/v4i1p007"},{"key":"5229_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jhep.2014.10.008","volume":"62","author":"M Lemoine","year":"2015","unstructured":"Lemoine M, Eholi\u00e9 S, Lacombe K. Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach. J Hepatol. 2015;62:469\u201376.","journal-title":"J Hepatol"},{"issue":"11","key":"5229_CR9","doi-asserted-by":"publisher","first-page":"e928","DOI":"10.1016\/j.ijid.2010.03.019","volume":"14","author":"S Jafari","year":"2010","unstructured":"Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. 2010;14(11):e928\u2013e40.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"5229_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1756-0500-7-239","volume":"7","author":"D Tegegne","year":"2014","unstructured":"Tegegne D, Desta K, Tegbaru B, Tilahun T. Seroprevalence and transmission of Hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa, Ethiopia: a cross sectional study. BMC research notes. 2014;7(1):239.","journal-title":"BMC research notes"},{"key":"5229_CR11","unstructured":"Bakthavatchalu S. Hepatitis B Surface Antigen Carrier State among Asymptomatic Pregnant Women and Its Correlation with Vertical Transmission. International Journal of Research in Pharmacy & Science. 2012;2(3)."},{"issue":"10","key":"5229_CR12","first-page":"1225","volume":"82","author":"N Camvulam","year":"2010","unstructured":"Camvulam N, Gotsch P, Langan RC. Caring for pregnant women and newborns with Hepatitis B or C. Am Fam Physician. 2010;82(10):1225\u20139.","journal-title":"Am Fam Physician"},{"issue":"10","key":"5229_CR13","first-page":"1225","volume":"82","author":"V Lam N-C","year":"2010","unstructured":"Lam N-C V, Gotsch PB, Langan RC. Caring for pregnant women and newborns with hepatitis B or C. Am Fam Physician. 2010;82(10):1225\u20139.","journal-title":"Am Fam Physician"},{"issue":"6","key":"5229_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jvh.12263","volume":"21","author":"J Howell","year":"2014","unstructured":"Howell J, Lemoine M, Thursz M. Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges. J Viral Hepat. 2014;21(6):381\u201396.","journal-title":"J Viral Hepat"},{"issue":"17","key":"5229_CR15","first-page":"13","volume":"17","author":"F Walle","year":"2008","unstructured":"Walle F, Asrat D, Alem A, Tadesse E, Desta K. Prevalence of hepatitis B surface antigen among pregnant women attending antenatal care service at Debre-Tabor Hospital. Northwest Ethiopia Ethiop J Health Sci. 2008;17(17):13\u201320.","journal-title":"Northwest Ethiopia Ethiop J Health Sci"},{"issue":"1","key":"5229_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1017\/S0950268803008574","volume":"131","author":"A Abebe","year":"2003","unstructured":"Abebe A, Nokes D, Dejene A, Enquselassie F, Messele T, et al. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiology & Infection. 2003;131(1):757\u201370.","journal-title":"Epidemiology & Infection"},{"issue":"8","key":"5229_CR17","first-page":"391","volume":"57","author":"N Siddiqi","year":"2007","unstructured":"Siddiqi N, Khan A, Nisar N, Siddiqi A. Assessment of EPI (expanded program of immunization) vaccine coverage in a peri-urban area. Jpma. 2007;57(8):391\u20135.","journal-title":"Jpma."},{"key":"5229_CR18","unstructured":"Ethiopia National Expanded Programme on Immunization: Comprehensive Multi-Year Plan 2016\u20132020. Federal Ministry of Health, Addis Ababa 2015:11."},{"key":"5229_CR19","first-page":"9","volume":"2013","author":"T Lenjiso","year":"2010","unstructured":"Lenjiso T, Tesfaye B, Michael A, Esatu T, Legessie Z. SNNPR Hawassa city Adminstration health department. GTP assessment report booklet. 2010-2012;2013:9\u201365.","journal-title":"GTP assessment report booklet"},{"issue":"6","key":"5229_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.4269\/ajtmh.2007.77.1079","volume":"77","author":"N Berhe","year":"2007","unstructured":"Berhe N, Myrvamg B, Gundersen SG. Intensity of Schisosoma mansoni, Hepatitus B, age and sex predict level of hepatic periportal thichkening\/ fibrosis (PPT\/F), a large scale community based study in Ethiopia. AM J Trop Med Hyg. 2007;77(6):1079\u201386.","journal-title":"AM J Trop Med Hyg"},{"key":"5229_CR21","unstructured":"WHO: Hepatitis B Fact Sheet;. 2008."},{"key":"5229_CR22","unstructured":"World health organization. Department of Communicable Diseases Surveillance and Response: Hepatitis B virus; . Geneva: 2002."},{"issue":"1","key":"5229_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2334-14-7","volume":"14","author":"TJ Peto","year":"2014","unstructured":"Peto TJ, Mendy ME, Lowe Y, Webb EL, Whittle HC, et al. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis intervention study (1986\u201390) and in the nationwide immunisation program. BMC Infect Dis. 2014;14(1):7.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"5229_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5009\/gnl.2012.6.2.235","volume":"6","author":"Y Cho","year":"2012","unstructured":"Cho Y, Bonsu G, Akoto-Ampaw A, Nkrumah-Mills G, Nimo JJ, et al. The prevalence and risk factors for hepatitis B surface Ag positivity in pregnant women in eastern region of Ghana. Gut and liver. 2012;6(2):235.","journal-title":"Gut and liver"},{"issue":"2","key":"5229_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0168-8278(05)80404-0","volume":"21","author":"P Coursaget","year":"2004","unstructured":"Coursaget P, Leboulleux D, Soumare M, le Cann P, Yvonnet B, et al. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol. 2004;21(2):250\u20134.","journal-title":"J Hepatol"},{"key":"5229_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijid.2015.04.020","volume":"36","author":"K Komada","year":"2015","unstructured":"Komada K, Sugiyama M, Vongphrachanh P, Xeuatvongsa A, Khamphaphongphane B, et al. Seroprevalence of chronic hepatitis B, as determined from dried blood spots, among children and their mothers in Central Lao People's Democratic Republic: a multistage, stratified cluster sampling survey. Int J Infect Dis. 2015;36:21\u20136.","journal-title":"Int J Infect Dis"},{"issue":"22","key":"5229_CR27","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.4254\/wjh.v7.i22.2418","volume":"7","author":"II Salama","year":"2015","unstructured":"Salama II, Sami SM, Said ZNA, El-Sayed MH, El Etreby LA, et al. Effectiveness of hepatitis B virus vaccination program in Egypt: multicenter national project. World J Hepatol. 2015;7(22):2418.","journal-title":"World J Hepatol"},{"key":"5229_CR28","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2471\/BLT.13.133413","volume":"92","author":"TT Lao","year":"2014","unstructured":"Lao TT, Sahota DS, Law L-W, Cheng YK, Leung T-Y. Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong special administrative region of China. Bull World Health Organ. 2014;92:782\u20139.","journal-title":"Bull World Health Organ"},{"key":"5229_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4236\/health.2015.74054","volume":"7","author":"H Ageely","year":"2015","unstructured":"Ageely H, Mahfouz MS, Gaffar A, Elmakki E, Elhassan I, et al. Prevalence and risk factors of Hepatitis B virus in Jazan region, Saudi Arabia: cross-sectional health facility based study. Health. 2015;7:459\u201365.","journal-title":"Health."},{"issue":"10","key":"5229_CR30","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1136\/jech.2009.092288","volume":"64","author":"JA Hontelez","year":"2010","unstructured":"Hontelez JA, Hahn\u00e9 S, Koedijk FH, de Melker HE. Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment. J Epidemiol Community Health. 2010;64(10):890\u20134.","journal-title":"J Epidemiol Community Health"},{"issue":"3","key":"5229_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4269\/ajtmh.14-0537","volume":"92","author":"R Kitau","year":"2015","unstructured":"Kitau R, Datta SS, Patel MK, Hennessey K, Wannemuehler K, et al. Hepatitis B surface antigen seroprevalence among children in Papua New Guinea, 2012\u20132013. The American journal of tropical medicine and hygiene. 2015;92(3):501\u20136.","journal-title":"The American journal of tropical medicine and hygiene"},{"key":"5229_CR32","unstructured":"Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, et al. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. African health sciences. 2009;9(2)."},{"issue":"4","key":"5229_CR33","first-page":"401","volume":"64","author":"Q Huma","year":"2014","unstructured":"Huma Q, Najma J, Syed EA, Khalif M. The evidence of mother to child transmission of hepatitis B virus infection in Pakistan and the need for hepatitis B immunization policy change. J Pak Med Assoc. 2014;64(4):401\u20135.","journal-title":"J Pak Med Assoc"},{"issue":"4","key":"5229_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0022-3476(79)80789-1","volume":"95","author":"E Tabor","year":"2009","unstructured":"Tabor E, Gerety RJ. Hepatitis B virus infection in infants and toddlers in Nigeria: the need for early intervention. J Pediatr. 2009;95(4):647\u201350.","journal-title":"J Pediatr"},{"key":"5229_CR35","unstructured":"Central Statistical Agency, Ethiopia Demographic and Health Survey; final draft report. Addis Ababa Ethiopia. ICF International Calverton, Maryland, USA. 2011."},{"issue":"1","key":"5229_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1086\/345871","volume":"187","author":"Y-C Lin","year":"2003","unstructured":"Lin Y-C, Chang M-H, Ni Y-H, Hsu H-Y, Chen D-S. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis. 2003;187(1):134\u20138.","journal-title":"J Infect Dis"},{"issue":"2","key":"5229_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97\u2013107.","journal-title":"J Viral Hepat"},{"issue":"49","key":"5229_CR38","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","volume":"26","author":"AR Zanetti","year":"2008","unstructured":"Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26(49):6266\u201373.","journal-title":"Vaccine."},{"key":"5229_CR39","volume-title":"Prevalence, infectivity, and associated risk factors of hepatitis B virus among pregnant women in Yirgalem hospital","author":"A Amsalu","year":"2018","unstructured":"Amsalu A, Ferede G, Eshetie S, Tadewos A, Assegu D. Prevalence, infectivity, and associated risk factors of hepatitis B virus among pregnant women in Yirgalem hospital. Implication of Screening to Control Mother-to-Child Transmission. Journal of pregnancy: Ethiopia; 2018."},{"key":"5229_CR40","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1016\/S0168-8278(18)30550-6","volume":"68","author":"D Razavi-Shearer","year":"2018","unstructured":"Razavi-Shearer D, Gamkrelidze I, Blach S, Brandon S, Estes C, et al. THU-097 - the global prevalence of HBsAg by age in 2016 and the case for universal treatment in low and middle income countries. J Hepatol. 2018;68:S169.","journal-title":"J Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05229-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05229-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05229-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T23:08:54Z","timestamp":1626908934000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05229-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5229"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05229-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"9 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Institutional Review Board of Armauer Hansen Research Institute and College of Medicine and Health Sciences, Hawassa University. The purpose and importance of the study were explained to each study participants<b>.<\/b> To ensure confidentiality of participant\u2019s codes numbers was used on the questionnaire. Participant was interviewed alone to keep the privacy. All participants were not paid for the test. Informed written consent was obtained from a parent or guardian for children to participate in the study. The study incurs no cost to the study participants and interviewed free of charge. Participants who have diagnosed and suspected cases was get proper advice and referred for further diagnosis, better treatment and care to nearest public health facilities.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare there is no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"528"}}